Summary
In the present investigation, the abilities of streptozotocin and alloxan to induce DNA repair synthesis in isolated mouse pancreatic islets have been compared using an autoradiographic technique. Streptozotocin exposure in vitro induced a dose-dependent DNA repair synthesis, whereas no such effect was observed after alloxan treatment. The hydroxyl radical scavenger dimethyl urea and the poly(ADP-ribose) synthetase inhibitors nicotinamide and theophylline reduced the streptozotocin-induced DNA repair. The results suggest that the initial events in streptozotocin-induced B cell injury are DNA damage and repair and that alloxan exerts its major cytotoxic effect by a different mechanism.
Article PDF
Similar content being viewed by others
References
Okamoto H (1981) Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes. Mol Cell Biochem 37: 43–61
Yamamoto H, Uchigata Y, Okamoto H (1981) Streptozotocin and alloxan induce DNA strand breaks and poly (ADP-ribose)synthetase in pancreatic islets. Nature 294: 284–286
Uchigata Y, Yamamoto H, Kawamura A, Okamoto H (1982) Protection by superoxide dismutase, catalase and poly(ADPribose)synthetase inhibitors against alloxanand streptozotocininduced islet DNA strand breaks and against the inhibition of proinsulin biosynthesis. J Biol Chem 257: 6084–6088
Claycombe WC (1976) Poly(adenosine diphosphate ribose) polymerase activity and nicotinamide adenine dinucleotide in differentiating cardiac muscle. Biochem J 154: 387–393
Smulson ME, Schein P, Mullins Jr DW, Sudhakar S (1977) A putative role for nicotinamide adenine dinucleotide-promoted nuclear protein modification in the antitumor activity of N-methylN-nitrosourea. Canc Res 37: 3006–3012
Levi V, Jacobson EL, Jacobson MK (1978) Inhibition of poly (ADP-ribose)polymerase by methylated xanthines and cytokinins. FEBS Lett 88: 144–146
Skidmore CJ, Davies MI, Goodwin PM, Halldorson H, Lewis PJ, Shall S, Ziaèe A-A (1979) The involvement of poly(ADP-ribose)polymerase in the degradation of NAD caused by γ-radiation and N-methyl-N-Nitrosurea. Eur J Biochem 101: 135–142
Howell SL, Taylor KW (1968) Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. Biochem J 108: 17–24
Krebs HA, Henseleit K (1932) Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe-Seylers Z Physiol Chem 210: 33–66
Hanawalt PC, Cooper PK, Ganesan AK, Smith CA (1979) DNA repair in bacteria and mammalian cells. Ann Rev Biochem 48: 783–836
Sandler S, Welsh M (1982) In vitro effects of streptozotocin (SZ) on (pro)insulin biosynthesis, contents of adenine and pyridine nucleotides and oxygen uptake in mouse pancreatic islets. Acta Endocrinol 100 Suppl 247: 54 (Abstract)
Robbins MJ, Sharp RA, Slonim AE, Burr IM (1980) Protection against streptozotocin-induced diabetes by superoxide dismutase. Diabetologia 18: 55–58
Marklund S, Grankvist K (1980) Polyethyleneglycol-superoxide dismutase (PEG-SOD) protect against streptozotocin-induced diabetes in mice. Acta Endocrionol 98 Suppl 245: 43 (Abstract)
Gandy SM, Buse MG, Crouch RK (1982) Protective role of superoxide dismutase against diabetogenic drugs. J Clin Invest 70: 650–658
Sandler S, Andersson A (1982) The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro. Diabetologia 23: 374–378
Gold G, Manning M, Heldt A, Nowlain R, Pettit JR, Grodsky GM (1981) Diabetes induced with multiple subdiabetogenic doses of streptozotocin. Lack of protection by exogenous superoxide dismutase. Diabetes 30: 634–638
Swenne I (1982) Effects of cyclic AMP on DNA replication and protein biosynthesis in fetal rat islets of Langerhans maintained in tissue culture. Bioscience Reports 2: 867–876
Sandler S, Welsh M (1982) Effects of nicotinamide on alloxan and streptozotocin induced mouse pancreatic B cell cytotoxicity in vivo and in vitro. Diabetologia 23: 197 (Abstract)
Schein PS, Cooney DA, Vernon ML (1967) The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. Canc Res 27: 2324–2332
Rerup C, Tarding F (1969) Streptozotocin and alloxan-diabetes in mice. Eur J Pharm 7: 89–96
Borg LAH, Eide SJ, Andersson A, Hellerström C (1979) Effects in vitro of alloxan on glucose metabolism of mouse pancreatic B-cells. Biochem J 182: 797–802
Boquist L (1980) A new hypothesis for alloxan diabetes. Acta Path Microbiol Scand Sect A 88: 201–209
Cooperstein SJ, Watkins D (1981) Action of toxic drugs on islet cells. In: Cooperstein SJ, Watkins D (eds) The islets of Langerhans. Academic Press, New York, pp 387–425
Grankvist K (1981) Mechanisms of alloxan diabetogenicity. Thesis. Umeå University Medical Dissertations 72: 1–38
Andersson T, Schein PS, McMenamin MG, Cooney DA (1974) Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide. J Clin Invest 54: 672–677
Gunnarsson R, Berne C, Hellerström C (1974) Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide. Biochem J 140: 487–494
Karunanayake EH, Baker JRJ, Christian RA, Hearse DJ, Mellows G (1976) Autoradiographic study of the distribution and cellular uptake of (14C)-streptozotocin in the rat. Diabetologia 12: 123–128
Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG (1982) Determinants of the selective toxicity of alloxan to the pancreatic B-cell. Proc Natl Acad Sci USA 79: 927–930
Gorus FK, Malaisse WJ, Pipeleers DG (1982) Selective uptake of alloxan by pancreatic B-cells. Biochem J 208: 513–515
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sandler, S., Swenne, I. Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro. Diabetologia 25, 444–447 (1983). https://doi.org/10.1007/BF00282526
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00282526